JD Health International (6618.HK) Earnings Analysis

JD Health International (6618.HK) next reports earnings on 2026-08-13, consensus EPS 1.35 HKD. It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 19.28.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 6618.HK next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate1.35 HKD
Revenue estimate47.66B

6618.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-051.04 HKDn/an/an/a
2025-08-140.885 HKD1.09 HKD-18.8%Miss
2025-03-050.724 HKD0.67 HKD+8.1%Beat
2024-08-150.697 HKD0.707 HKD-1.4%Miss

Beat rate: 1/3 (33%) over reported quarters with consensus data.

6618.HK valuation and analyst view

Trailing P/E19.28
Trailing EPS1.683 HKD
Price / book1.72
Dividend yield0.00%
Market cap120.99B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is JD Health International (6618.HK)'s next earnings date?

JD Health International is next scheduled to report on 2026-08-13, with a consensus EPS estimate of 1.35 HKD and revenue estimate of 47.66B.

Did 6618.HK beat earnings last quarter?

Consensus estimate data was not available for 6618.HK's 2026-03-05 report.

What is 6618.HK's earnings track record?

Over the last 3 reported quarters with consensus data, 6618.HK beat estimates 1 times (33%).

What is 6618.HK's current P/E ratio and EPS?

6618.HK trades at a trailing P/E of 19.28 on trailing EPS of 1.6826246335049346 HKD.

What do analysts rate 6618.HK?

6618.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.